Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study.
Nomura A, Masuda T, Shimoji K, Takao S, Izumi Y, Araki Y, Takayama Y, Masuda K, Yamaguchi K, Sakamoto S, Horimasu Y, Nakashima T, Iwamoto H, Senoo T, Shoda H, Ishikawa N, Yamasaki M, Hamada H, Okada M, Hattori N.
Nomura A, et al. Among authors: araki y.
Transl Lung Cancer Res. 2026 Mar 23;15(3):59. doi: 10.21037/tlcr-2025-aw-1281. Epub 2026 Feb 26.
Transl Lung Cancer Res. 2026.
PMID: 41982699
Free PMC article.